• D-mannose for preventing and treating urinary tract infections in adults and children 2020 Abstracts
• D.I.C.E. therapy: an overview of the randomised trials 1994 Hamilton
• Dan Shen agents for acute ischaemic stroke 2004 Ottawa
• Data Abstraction Assistant (DAA) – What can it do and does it work? 2017 Cape Town [Global Evidence Summit]
• Data Abstraction Assistant (DAA): a new open-access tool being developed and tested in a randomized controlled trial 2016 Seoul
• Data Abstraction Assistant, a new tool, saves time without compromising the accuracy of data abstraction during systematic reviews 2018 Edinburgh
• Data analysis and presentation methods in umbrella reviews/ overviews of reviews: a cross-sectional study 2024 Prague [Global Evidence Summit]
• Data cleaning in the Cochrane Register of Studies 2013 Québec City
• Data completeness and quality: the results of the Australian New Zealand Clinical Trials Registry 2011 data audits 2012 Auckland
• Data extraction and analysis of data on adverse effects in systematic reviews 2019 Santiago
• Data extraction errors in meta-analyses using standardised mean differences 2007 Sao Paulo
• Data extraction problems associated with RCTS of cross-over design assessing the effects of medical treatment for menorrhagia 1997 Amsterdam
• Data integrity of 35 randomised controlled trials in women’ health 2020 Abstracts
• Data management in real-world study 2019 Santiago
• Data maturity and systematic reviews of new health technologies 2004 Ottawa
• Data reuse, machine learning, and crowdsourcing in Screen4Me: how screening burden can be reduced substantially and reliably 2019 Santiago
• Data sharing policies across the health research lifecycle: a cross-sectional analysis of global funders, ethics committees, trial registries, journals and data repositories 2023 London
• Data sharing: experiences accessing individual participant data for a collaborative meta-analysis on umbilical cord management strategies at preterm birth. 2023 London
• Data sharing: is it getting easier to access individual participant data? Experiences from the Cochrane Epilepsy Group 2014 Hyderabad
• Data sovereignty and governance—should we be considering this in systematic reviews? 2024 Prague [Global Evidence Summit]
• Data synthesis in drug class reviews aimed at public health policy audiences: further development of optimal models is needed 2006 Dublin
• Database of appraised studies on patients’ values and preferences 2014 Hyderabad
• Database of patients’ organizations in Latin America & the Caribbean 2008 Freiburg
• Database search of trial registries to identify unpublished data for cancer-related systematic reviews 2017 Cape Town [Global Evidence Summit]
• Database searching in manual medicine 1994 Hamilton
• De-duplication: new methods to reduce the manual burden of systematic searches 2018 Edinburgh
• Dealing with complexity in systematic reviews through outcome categorisation and selection 2014 Hyderabad
• Dealing with conceptual and methodological issues in reviews Of complex interventions: Reflections on a review of interventions to promote patient centred care 2000 Cape Town
• Dealing with Drop-outs in Clinical Trials and Meta-analyses 1999 Rome
• Dealing with heterogeneity 2008 Freiburg
• Dealing with heterogeneity in treatment implementation: an example from music therapy in psychiatry 2004 Ottawa
• Dealing with methodologic challenges in systematic reviews addressing baseline risk 2016 Seoul
• Dealing with missing data in an individual participant data meta-analysis: one-­stage versus two­-stage methods 2016 Seoul
• Dealing with publication bias 2013 Québec City
• Dealing With Publication Bias: Different Mechanisms For Different Types Of Studies? 1999 Rome
• Dealing with retrieval bias for an evidence-informed individual patient data network meta-analysis 2020 Abstracts
• Debunking the Shadows: Common myths and misconceptions about evidence-based practice 2024 Prague [Global Evidence Summit]
• DEC-NET: the European register of clinical trials on medicines for children 2005 Melbourne
• Deciding when a guideline will stand the test of time – the use of a static list 2017 Cape Town [Global Evidence Summit]
• Deciding when to include non-randomized studies of interventions in a Cochrane Review of an intervention 2018 Edinburgh
• Deciding when to make a Cochrane Review update the final iteration 2020 Abstracts
• Decision aids from current systematic reviews for the clinical encounter 2013 Québec City
• Decision antecedents and outcomes of shared decision-making in patients with lumbar degenerative diseases 2019 Santiago
• Decision makers find it difficult to compare and select similar systematic reviews based on quality, methods and results: a cross-sectional survey 2023 London
• Decision making about healthcare-related tests and diagnostic strategies: A framework provides guidance for when research providing test-accuracy information is sufficient 2017 Cape Town [Global Evidence Summit]
• Decision support for use automation tools in selecting references during systematic reviews 2024 Prague [Global Evidence Summit]
• Decision-makers’ perceptions and use of HTAs produced by an Argentinean agency: a qualitative study and a survey 2016 Seoul
• Declarations and conflicts of interest in WHO guidelines 2017 Cape Town [Global Evidence Summit]
• Decoding semi-automated title-abstract screening: an exploration of the review, study, and publication characteristics associated with Abstrackr's relevance predictions 2020 Abstracts
• Deficient reporting and interpretation of non-inferiority clinical trials in antiretroviral-na"ive HIV patients: A systematic review 2011 Madrid
• Defining and assessing the certainty of evidence for diagnostic test accuracy in systematic reviews, health technology assessments, and guidelines 2017 Cape Town [Global Evidence Summit]
• Defining and evaluating quality of evidence in 'Summary of findings' tables 2015 Vienna
• Defining and evaluating quality of evidence in Cochrane Reviews 2016 Seoul
• Defining appropriateness criteria for performance measures 2017 Cape Town [Global Evidence Summit]
• Defining misinformation and related terms: a scoping review of the health-related literature 2023 London
• Defining Racial Health Equity (RHE): A Landscape Review of Definitions, Terminology and Related Concepts 2023 London
• Defining ranges for certainty ratings of diagnostic accuracy 2018 Edinburgh
• Defining Rapid Reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews 2020 Abstracts
• Defining study designs in The Cochrane Collaboration: Do all Cochrane Review Groups talk the same language? 2011 Madrid
• Defining variation in outcome reporting: a review of systematic reviews in women’s and newborns' health 2018 Edinburgh
• Definitely Maybe: How is uncertainty expressed in Cochrane reviews? 2000 Cape Town
• Definition and reporting of composite outcomes in randomized clinical trials on pharmacological interventions for coronary artery disease 2024 Prague [Global Evidence Summit]
• Definition of eligibility for non-randomised studies in 113 Cochrane Reviews of interventions to prevent healthcare-associated infections 2018 Edinburgh
• Definition, disclosure and management of conflicts of interest in clinical practice guidelines: A systematic review 2017 Cape Town [Global Evidence Summit]
• Definitions and Themes of “Racial Health Equity”: A Systematic Review 2024 Prague [Global Evidence Summit]
• Definitions of intention-to-treat in the face of missing outcome data: A systematic survey of methodology papers 2011 Madrid
• Deja vu: a new database tool complementing systematic reviews in detecting duplicate publications 2008 Freiburg
• Delivering evidence in a patient-focused manner: the example of the European Breast Guidelines 2018 Edinburgh
• Delivering on priorities: developing and implementing effective collaboration between a Cochrane Review Group (CRG) and a Cochrane Field 2008 Freiburg
• Delivery arrangements for health systems in low-income countries: an overview of systematic reviews 2014 Hyderabad
• Delphi list: a consensus criteria list to assess trial quality 1997 Amsterdam
• Delphi Method and Analytic Hierarchy Process to establish an indicator system to evaluate rational drug use in children with primary nephrotic syndrome 2018 Edinburgh
• Delphi's twin: a method to improve the quality of standards in medicine 1996 Adelaide
• Dementia guidelines in Europe: the EuroCoDe database and consensus guideline 2008 Freiburg
• Dementia-friendly environmental assessment and management of patient with dementia in community: a best practice implementation project 2024 Prague [Global Evidence Summit]
• Demonstrating evidence-based practice 1997 Amsterdam
• Demonstrating evidence-based practice 1997 Amsterdam
• Demonstration of DIPEX: A Database of Individual Patient Experiences 1999 Rome
• Demystifying clinical trials and systematic reviews for the public ***in computer lab; no need for personal laptops 2013 Québec City
• Demystifying R Part 1: How to use Shiny apps in information retrieval 2023 London
• Demystifying R Part 2: An introduction to coding in R and RStudio 2023 London
• Dependent observations in RCTs regarding carpal tunnel syndrome 1997 Amsterdam
• Deprescribing reduces mortality in older adults: a systematic review 2015 Vienna
• depressionscreening100.com/phq: a practice-based perspective to using the Patient Health Questionnaire-9 to screen for depression 2020 Abstracts
• Depth and breadth: orienting evidence synthesis toward the Sustainable Development Goals 2030 Agenda 2024 Prague [Global Evidence Summit]
• Deriving percentage study weights in advanced meta-analysis models 2018 Edinburgh
• Describing a user-centred approach to developing key clinical questions for guidelines for general practitioners 2017 Cape Town [Global Evidence Summit]
• Describing and quantifying the gap between proof and practice 2004 Ottawa
• Describing complex interventions: An example from strike rehabilitation 1999 Rome
• Describing Heterogeneity in Meta-analysis Involving Cluster Randomized Trials: Normality versus Nonparametric Approaches of Random Effects Models 2002 Stavanger
• Describing rare and serious harms of interventions 2007 Sao Paulo
• Description of the protocols of randomized controlled trials on cancer drugs conducted in Spain (1999-2003) 2014 Hyderabad
• Description of trials and systematic reviews exclusively retrieved by LILACS 2018 Edinburgh
• Descriptive analysis of current levels of Cochrane Collaboration hand search activities 1998 Baltimore
• Descriptive analysis of non-randomized studies included in Cochrane Reviews regarding their availability in PubMed 2018 Edinburgh
• Descriptive analysis of the first 1000 trials in Pan African Clinical Trial Registry (PACTR) 2018 Edinburgh
• Descriptive analysis of timing of clinical trial registration and publication in ICMJE accredited journals 2012 Auckland
• Descriptive Evaluation of Pediatric Comorbidity Cohort Studies：A Scoping review 2024 Prague [Global Evidence Summit]
• Design and development of an application to extend the diffusion of Cochrane Mexico 2019 Santiago
• Design and validation of a questionnaire for the detection of major depression in older patients 2004 Ottawa
• Design and validation of a search filter for LGBTQ+ populations 2018 Edinburgh
• Design characteristics and performance of diagnostic tests. A systematic review on the value of tissue polypeptide antigen (TPA) in the diagnosis of lung cancer 1998 Baltimore
• Design characteristics influencing performance of prognostic models upon external validation: A meta-epidemiological study 2017 Cape Town [Global Evidence Summit]
• Design characteristics of external validation studies influencing the performance of risk prediction models 2016 Seoul
• Design related bias and sources of variation in diagnostic accuracy studies 2004 Ottawa
• Design, conduct, and analysis of safety among drug systematic reviews: a cross-sectional survey 2019 Santiago
• Design, conduct, and analysis of safety among drug-related systematic reviews: A cross-sectional survey 2020 Abstracts
• Designing a social media strategy for a Cochrane entity 2013 Québec City
• Designing a trial protocol on the basis of the findings of Cochrane reviews - the IMPLEMEG study 2004 Ottawa
• Designing an Efficient and Precise Search Strategy for Observational Studies 2002 Stavanger
• Designing and implementing a Latin-American clinical trials registry (LATINREC) 2005 Melbourne
• Designing and validating an online survey to measure understanding and attitudes toward evidence-based medicine among clinicians 2004 Ottawa
• Designing Decision Aids Derived from Clinical Practice Guidelines: Insights from a Single-Center Experience in Spain and Future Perspectives 2024 Prague [Global Evidence Summit]
• Designing patient versions of SIGN guidelines with service users 2017 Cape Town [Global Evidence Summit]
• Designs and analysis of N-of-1 trials: A systematic review 2011 Madrid
• Desk rejections of high-quality evidence synthesis about appropriateness of advanced cancer treatments are a frequent publishing challenge: Experience from ASTAC-Project 2024 Prague [Global Evidence Summit]
• Detecting and Adjusting for Publication Bias in Meta-Analysis: A Systematic Review 1999 Rome
• Detecting publication bias in systematic reviews of diagnostic test accuracy 2004 Ottawa
• Detection Of Outlying And Influential Trials: A Graphical Method To Explore Heterogeneity In Meta-Analysis 1999 Rome
• Determinant factors of personal recovery in persons with schizophrenia in Asia: a systematic review and meta-analysis 2024 Prague [Global Evidence Summit]
• Determinants for successful de-implementation of low-value services: a systematic review 2016 Seoul
• Determining appropriate inclusion criteria for reviews of public health interventions: Skin cancer prevention as a case study 2011 Madrid
• Determining study design classification of potential trial reports using MEDLINE abstracts 2005 Melbourne
• Determining the causes of apparent life threatening events (ALTEs) 2004 Ottawa
• Determining the credibility of minimal important differences (MIDs) for application in meta-analysis of patient-reported outcomes in systematic reviews and guidelines 2019 Santiago
• Determining the degree of dissemination bias for health-related quality of life outcomes in antidepressant trials 2018 Edinburgh
• Determining the importance of outcomes used for evaluating therapies for children with asthma 2010 Keystone
• Determining the inter-reviewer reliability of literature screening for human and machine-assisted systematic reviews: A mixed methods review 2023 London
• Determining the KSTE priorities for the National Collaborating Centre for Methods and Tools (Public Health in Canada) 2007 Sao Paulo
• Determining the primary endpoints for diagnostic test accuracy reviews of substance use disorders 2020 Abstracts
• Determining the role of patient values and preferences in the development and review of preference-sensitive practice guidelines 2011 Madrid
• Develop a clinical practice guideline on acupuncture-related treatments to alleviate functional constipation 2024 Prague [Global Evidence Summit]
• Develop accelerated guidelines, based on a selective literature search 2017 Cape Town [Global Evidence Summit]
• Developing “EBPM Database” to Improve Policy Making Process in Japan. 2024 Prague [Global Evidence Summit]
• Developing a checklist for assessing quality of clinical trials in psychiatry 1997 Amsterdam
• Developing a checklist to assess quality of reporting of knowledge translation interventions using the WIDER Recommendations 2013 Québec City
• Developing a child health trials register: benefits, challenges, and solutions 2008 Freiburg
• Developing a classification system for a systematic review of the prognosis of autism 2007 Sao Paulo
• Developing a Cochrane Child Health knowledge translation plan: why, how, and for whom? 2018 Edinburgh
• Developing a conceptual framework for going from evidence to coverage decisions 2013 Québec City
• Developing a conceptual framework to support coverage decisions for vaccines adoption: a Delphi consensus process 2015 Vienna
• Developing a core outcome set for assessing clinical safety outcomes of cardiovascular diseases in clinical trials of integrated traditional Chinese medicine and Western medicine 2023 London
• Developing a critical appraisal skills programme for consumers 1995 Oslo
• Developing a data management software for systematic reviews and meta-analyses 2007 Sao Paulo
• Developing a database structure for meta-epidemiological research 2008 Freiburg
• Developing a deeper understanding of the impacts of lay health worker interventions: combining systematic reviews of effectiveness and cost-effectiveness with a realist review of programme theory 2008 Freiburg
• Developing a diversity and inclusion Cochrane US Mentoring Program 2023 London
• Developing a fictitious review as a training resource for Cochrane authors 2008 Freiburg
• Developing a Framework for building synergies between the selection of essential medicines and their use in practice guidelines 2020 Abstracts
• Developing a framework for systematic reviews of health disparities 2024 Prague [Global Evidence Summit]
• Developing a Handbook for Developing Clinical Care Protocols in Cancer Management. Part II: Steps for Protocol Elaboration. A systematic review. 2017 Cape Town [Global Evidence Summit]
• Developing a Handbook to generate evidence-based clinical care protocols in cancer care. Part I. Handbook construction 2017 Cape Town [Global Evidence Summit]
• Developing a Learning System for a Practice Monitor Molecular Diagnostics in Oncology 2024 Prague [Global Evidence Summit]
• Developing a model workshop for systematic review protocols at teaching hospitals: midterm report of action research 2016 Seoul
• Developing a parent advisory group to inform a knowledge translation research program 2018 Edinburgh
• Developing a Participatory Evidence and Gap Map (EGM): discussing challenges and possible solutions 2024 Prague [Global Evidence Summit]
• Developing a policy for managing reviews across more than one Cochrane Review Group 2006 Dublin
• Developing a policy on peer review for Cochrane Reviews 2016 Seoul
• Developing a Preferred Reporting Items for Development of Evidence based Clinical Practice Guideline in Traditional Medicine (PRIDE-CPG-TM) 2015 Vienna
• Developing a published evidence map as a tool to identify and prioritise intervention types in Type-2 Diabetes management 2017 Cape Town [Global Evidence Summit]
• Developing a rapid response system within systematic review centers to address priority needs from policymakers 2016 Seoul
• Developing a search filter for ‘upstream’ public health interventions 2008 Freiburg
• Developing a search filter for identifying primary care studies in general medical journals 2011 Madrid
• Developing a search strategy for a scoping review of adaptation to climate change 2019 Santiago
• Developing a search strategy for a scoping review of adaptation to climate change 2024 Prague [Global Evidence Summit]
• Developing a search strategy for controlled trials in LILACS (Latin American and Caribbean Literature on the Health Sciences database) 2006 Dublin
• Developing a sensitive search strategy for retrieving reports of randomized trials in Iranmedex 2006 Dublin
• Developing a sensitive search strategy in Farsi for retrieving reports of randomized trials in Iranmedex 2008 Freiburg
• Developing a set of contextualized guideline-based metrics to evaluate delirium care quality for older adults in the emergency department 2024 Prague [Global Evidence Summit]
• Developing a set of early learning and development standards (ELDS) for children aged 0-6 in Egypt 2024 Prague [Global Evidence Summit]
• Developing a statement of principles for consumer involvement in Cochrane 2016 Seoul
• Developing a taxonomy for rapid review products and their methodological approaches 2015 Vienna
• Developing a taxonomy to organise and conceptualise evidence on communication interventions to improve vaccination in low- and middle-income countries 2012 Auckland
• Developing a Technological Platform for Collection and Utilization of Patient Reported Data in Ontario Health Teams 2020 Abstracts
• Developing a toolkit for Involving a multi-ethnic group in an evidence-based research process 2023 London
• Developing a typology of activities for linking research evidence to research use 2011 Madrid
• Developing a web-based international register of clinical prediction rules for primary care 2011 Madrid
• Developing a WHO Rapid Advice Guideline (RAG) in the setting of a public health emergency 2015 Vienna
• Developing a workforce of systematic reviewers out of primary researchers: a mechanism to increase the value and reduce the waste 2018 Edinburgh
• Developing an effective search strategy for systematic reviews and other evidence syntheses 2017 Cape Town [Global Evidence Summit]
• Developing an evidence-based guideline for preventing and managing diabetic foot problems 1996 Adelaide
• Developing an Evidence-based Questionnaire and Evaluating Health Information Literacy for Chinese Residents 2023 London
• Developing an innovative Knowledge and Implementation Hub: a one-stop shop to support knowledge transfer in aged care in Australia 2024 Prague [Global Evidence Summit]
• Developing an ontology centred on the PICO (patient, intervention, comparison, outcome) model to support the linkage of Cochrane evidence to promote its usability and discoverability 2019 Santiago
• Developing an organizational change process model and online toolkit to assist public health professionals with evidence-informed decision making 2018 Edinburgh
• Developing an overview of systematic reviews: a framework for synthesising the evidence on interventions to improve communication with, 2005 Melbourne
• Developing an R package for dynamic and web-based updating of reviews 2017 Cape Town [Global Evidence Summit]
• Developing and applying priority-setting criteria for complex interventions across diseases 2015 Vienna
• Developing and designing INVITES-IN; a tool for assessing the internal validity of in vitro studies 2024 Prague [Global Evidence Summit]
• Developing and implementing a free, online course on peer review of the biomedical literature 2012 Auckland
• Developing and institutionalising evidence systems to suit local contexts: political and economic dimensions for envisaging the next steps 2024 Prague [Global Evidence Summit]
• Developing and integrating evidence maps into public-health decision making 2017 Cape Town [Global Evidence Summit]
• Developing and operationalizing a guideline methodologist competency framework 2024 Prague [Global Evidence Summit]
• Developing and piloting an adaptation of AMSTAR tool for systematic reviews of research priority setting exercises 2023 London
• Developing and testing a ‘one-stop shop’ for policy-relevant systematic reviews about social policies and systems 2017 Cape Town [Global Evidence Summit]
• Developing and testing an optimal search strategy for identifying studies of prognosis 2006 Dublin
• Developing and validating a tool to quantify risk of bias in systematic reviews of genetic association studies 2015 Vienna
• Developing and validating geographic search filters for use in systematic literature searches 2016 Seoul
• Developing capacity for evidence-informed decision making within public health organizations 2019 Santiago
• Developing capacity for the production and use of Living Evidence in decision making: The LE to Inform Health decisions project. 2023 London
• Developing clinical practice guidelines for low-to-middle income countries: Methods, experiences and lesson learnt in adapting, adopting or contextualising existing CPGs 2017 Cape Town [Global Evidence Summit]
• Developing clinical prediction model based on meta-analysis method: a cross-sectional survey and methodological summaries 2024 Prague [Global Evidence Summit]
• Developing clinical standards for schizophrenia in Scotland : How useful are Cochrane reviews? 2000 Cape Town
• Developing clinically meaningful criteria of ‘response’ that can be used as standards in systematic reviews by equipercentile linking 2008 Freiburg
• Developing consensus when tackling highly technical and emotive challenges: an observational study of JLA Preterm Birth Priority Setting Partnership 2016 Seoul
• Developing core competencies for scientific editors of biomedical journals 2015 Vienna
• Developing cost effectiveness in guidelines 1997 Amsterdam
• Developing cost effectiveness in guidelines 1997 Amsterdam
• Developing country challenges, solutions and partnerships 2006 Dublin
• Developing digital gender-inclusive tools for evidence-use in Uganda and South Africa: insights, prototypes, and joint learnings 2024 Prague [Global Evidence Summit]
• Developing digital resources to teach secondary school students to think critically about health information and choices: human-centred design 2023 London
• Developing dissemination strategies for systematic reviews: the Centre for Reviews and Dissemination (CRD) approach 2006 Dublin
• Developing efficient search strategies to identify papers on adverse events. A: testing and precision sensitivity 2004 Ottawa
• Developing efficient search strategies to identify papers on adverse events. B: using statistical analysis 2004 Ottawa
• Developing evidence in a responsive approach 2013 Québec City
• Developing evidence-based guidelines for infectious and neglected tropical diseases in Brazil 2017 Cape Town [Global Evidence Summit]
• Developing evidence-based guidelines on minor ailments in the absence of evidence 2024 Prague [Global Evidence Summit]
• Developing evidence-based practice skills in the public health workforce 2008 Freiburg
• Developing evidence-based quality indicators in primary health care: a practical 8-step approach 2024 Prague [Global Evidence Summit]
• Developing GRADE guidance for overviews of systematic reviews 2017 Cape Town [Global Evidence Summit]
• Developing guidelines across health and social care sectors: the experience of the guidelines on homelessness and mental health disorders (France) 2024 Prague [Global Evidence Summit]
• Developing guidelines to address health equity in chronic kidney among First Nations Peoples in Australia and Aotearoa New Zealand 2024 Prague [Global Evidence Summit]
• Developing guidelines to inform practice in social welfare and education 2024 Prague [Global Evidence Summit]
• Developing high-quality nutritional recommendations based on dose-response meta-analysis to elicit consumer values and preferences 2019 Santiago
• Developing infection prevention and control guidelines for healthcare professionals in the Netherlands: a development process evaluation 2024 Prague [Global Evidence Summit]
• Developing infographics to communicate COVID-19 rapid review conclusions in South Africa 2023 London
• Developing meaningful collaborations between consumers and Cochrane Review Groups in peer review 2018 Edinburgh
• Developing methodology for systematic reviews addressing questions of prevalence 2016 Seoul
• Developing methodology for validation and comparison of surrogate markers in randomized clinical trials 2004 Ottawa
• Developing methods for assessing implementation in effectiveness reviews: Challenges and progress 2013 Québec City
• Developing Methods for Identifying Retracted Studies affecting Systematic Reviews 2024 Prague [Global Evidence Summit]
• Developing National policy by identifying factors for tobacco smoking initiation among children in Malaysia 2024 Prague [Global Evidence Summit]
• Developing normative estimates for small sick newborn care in level-2 facilities in low and middle income countries 2024 Prague [Global Evidence Summit]
• Developing optimal search strategies for retrieval of clinical trials in LILACS database 2015 Vienna
• Developing optimal search strategies of clinical pathways in PubMed 2017 Cape Town [Global Evidence Summit]
• Developing plain language summaries for Cochrane diagnostic test accuracy (DTA) reviews 2014 Hyderabad
• Developing plain language summaries for Cochrane DTA reviews 2016 Seoul
• Developing Quality Guidelines for Observational Empirical Work 2010 Keystone
• Developing rapid evidence summaries to aid deci­sion making following a natural disaster 2009 Singapore
• Developing scoring system to inform the reliability of evidence about magnitude of invasive pneumococcal disease in Indian children 2020 Abstracts
• Developing search strategies for systematic reviews of diagnostic test accuracy (DTA) (restricted) 2013 Québec City
• Developing service delivery guidelines on acute medical emergencies: Challenges and solutions 2017 Cape Town [Global Evidence Summit]
• Developing software for combining search queries to design efficient search strategies 2011 Madrid
• Developing strategies for effective media advocacy and public understanding of evidence-informed health care 2014 Hyderabad
• Developing strategies to create evidence-based medicine culture in China 2000 Cape Town
• Developing Summary of Findings (SoF) tables for Cochrane reviews 2008 Freiburg
• Developing summary of findings tables in network meta-analysis: a user testing study 2016 Seoul
• Developing Summary of Findings Tables in Network Meta-Analysis: A user-testing study 2017 Cape Town [Global Evidence Summit]
• Developing systematic reviews on emerging topics: production of impactful intervention reviews with a limited evidence base. 2024 Prague [Global Evidence Summit]
• Developing the CAT HPPR - a critical appraisal tool to assess the quality of systematic-, rapid-, and scoping-reviews investigating interventions in health promotion and prevention 2020 Abstracts
• Developing the evidence-base Clinical Practice Guideline of Retinopathy of prematurity for Latin-American: An effort of PAHO, Cochrane STI and GIN Iberoamerican. 2017 Cape Town [Global Evidence Summit]
• Developing the OKCPG platform: accelerating the transition of text-based clinical practice guidelines to the digital era 2024 Prague [Global Evidence Summit]
• Developing the process model for the use of evidence in schools 2024 Prague [Global Evidence Summit]
• Developing the specialised register for the Cochrane Effective Practice and Organisation of Care Review Group (EPOC) 1998 Baltimore
• Developing the updating strategy for the European Breast Guidelines within the European Commission Initiative on Breast Cancer 2018 Edinburgh
• Developing visual social media content and learning new strategies for disseminating #CochraneEvidence - 'Reaching a more diverse audience' 2019 Santiago
• Developing, disseminating and implementing national evidence based guidelines for UK primary care: back pain as an example 1997 Amsterdam
• Development a guidance and checklist for reporting social work intervention trials - An Explanation and Elaboration of CONSORT statement 2024 Prague [Global Evidence Summit]
• Development and application of the ACTIVE framework to describe stakeholder involvement in systematic reviews 2018 Edinburgh
• Development and application of the RD-10 critical appraisal checklist in a systematic review of 181 regression discontinuity studies 2018 Edinburgh
• Development and assessment of a blended learning module for educating a general audience about Evidence-Based Practice 2017 Cape Town [Global Evidence Summit]
• Development and co-design of a behavioral activation intervention targeting depression among people with dementia for the Swedish context 2023 London
• Development and communication of health-systems evidence in China 2017 Cape Town [Global Evidence Summit]
• Development and evaluation of ‘Summary of findings’ tables for Cochrane reviews 2008 Freiburg
• Development and evaluation of a point-of-care tool for providers based on a meta-analysis and clinical practice guideline 2013 Québec City
• Development and evaluation of a point-of-care tool for providers based on a meta-analysis and clinical practice guideline 2013 Québec City
• Development and Evaluation of a Study Designs Typology for Medical Literature of Intervention 2011 Madrid
• Development and evaluation of a tool to orient guideline group members 2019 Santiago
• Development and evaluation of doktormitSDM, an approach to improving SDM in daily clinical practice – a continuum of increasing evidence 2015 Vienna
• Development and implementation of activities and materials that support healthcare professional-facilitated patient education to improve asthma management in Singapore. 2024 Prague [Global Evidence Summit]
• Development and implementation of evidenced-based medicine programs for a health insurance company in Brazil 2004 Ottawa
• Development and Implementation of the Ontario Health (Cancer Care Ontario) Fear of Cancer Recurrence Guideline 2024 Prague [Global Evidence Summit]
• Development and pilot of a framework using automation and crowd-sourcing to identify and classify randomized controlled trials for rheumatoid arthritis drug therapy 2020 Abstracts
• Development and pilot testing of evidence-based informed consent forms for total knee arthroplasty and anesthesia 2024 Prague [Global Evidence Summit]
• Development and prevalidation of a patient-reported outcome measure assessing medication treatment satisfaction for children and teenagers aged 8-18 years (MTSI-CT) 2024 Prague [Global Evidence Summit]
• Development and regular update of a meta-analytic database of randomized controlled trials: the case of psychological treatments for anxiety disorders 2020 Abstracts
• Development and testing of a tool to foster shared decision-making between patients and health care professionals in clinical practice guidelines 2024 Prague [Global Evidence Summit]
• Development and translation into English of criteria for the prospective assessment of the need for updating guideline recommendations: AGIL-criteria 2024 Prague [Global Evidence Summit]
• Development and use of a new risk of bias (ROB) tool for use in paired sample (in-vitro) laboratory studies 2024 Prague [Global Evidence Summit]
• Development and validation of a Core Outcome Set for Work and other plans to improve evidence synthesis in occupational health 2024 Prague [Global Evidence Summit]
• Development and validation of a novel instrument for assessing the quality of individual patient data meta-analysis 2013 Québec City
• Development and validation of a questionnaire to measure people’s ability to assess claims about treatment effects (CLAIM) 2015 Vienna
• Development and validation of a search filter for studies on patient’s values and preferences 2017 Cape Town [Global Evidence Summit]
• Development and validation of an Objective Structured Clinical Examination (OSCE) model for assessing Evidence-Based Medicine (EBM) competency 2023 London
• Development and validation of two sensitive and precise search filters for retrieval of clinical practice guidelines 2020 Abstracts
• Development and validity testing of the AGREE-HS, a health systems guidance quality-appraisal tool 2017 Cape Town [Global Evidence Summit]
• Development and validity testing of the AGREE-REX, a tool to evaluate the clinical credibility and implementability of clinical practice guideline recommendations 2017 Cape Town [Global Evidence Summit]
• Development of a bibliographic database in response to COVID-19 2020 Abstracts
• Development of a cardiac outcomes register in the West Moreton region of Queensland 1996 Adelaide
• Development of a centralized trials registry for research on HIV/AIDS prevention, intervention, and treatment: issues and considerations 1998 Baltimore
• Development of a checklist to assess implementation (Ch-IMP) in systematic reviews: the case of provider-based programs targeting children and youth 2015 Vienna
• Development of a Chinese-language bibliographic database in response to COVID-19 2020 Abstracts
• Development of a clinical guideline about postmortem radiology, including the perspective of relatives and development of a network 2017 Cape Town [Global Evidence Summit]
• Development of a combined data set of meta-epidemiological studies 2006 Dublin
• Development of a Comprehensive tool to Assess Rigor when Evaluating Quality Improvement projects—CARE-QI 2024 Prague [Global Evidence Summit]
• Development of a consensus criteria list to assess trial quality in systematic reviews 1996 Adelaide
• Development of A Core Outcome Set (COS) for Psoriasis in Clinical Research of Uyghur Medicine 2024 Prague [Global Evidence Summit]
• Development of a core outcome set for infant colic 2015 Vienna
• Development of a critical-appraisal tool for hospital clinical practice guideline in Cipto Mangunkusumo General Hospital, Indonesia 2017 Cape Town [Global Evidence Summit]
• Development of a database of studies examining methodologies used in controlled trials and systematic reviews 1994 Hamilton
• Development of a decision tool for updating Cochrane reviews 2008 Freiburg
• Development of a free tool for data estimation and conversion for meta-analysis (DECoMA) 2023 London
• Development of a generic working definition of 'supportive care' 2010 Keystone
• Development of a health-system guidance implementation tool using a modified Delphi method and a formative evaluation approach 2023 London
• Development of a living database of randomized controlled trials 2019 Santiago
• Development of a living registry of all randomised controlled trials in juvenile idiopathic arthritis 2023 London
• Development of a living, unified PRISMA statement to improve uptake and adherence of PRISMA and its extensions. 2024 Prague [Global Evidence Summit]
• Development of a method to evaluate patient explanations using electronic medical records 2017 Cape Town [Global Evidence Summit]
• Development of a methodological framework for systematic review-based evidence briefings 2011 Madrid
• Development of a methodological PubMed search filter for finding studies on measurement properties of outcome measures 2008 Freiburg
• Development of a new instrument to assess the credibility of effect modification 2018 Edinburgh
• Development of a new prioritization method for health technology assessment 2005 Melbourne
• Development of a practical and efficient methodology for determining whether to update a systematic drug class review: The DERP experience 2007 Sao Paulo
• Development of a prioritization toolbox for the WHO Priority Assistive Product List 2024 Prague [Global Evidence Summit]
• Development of a quality appraisal tool for case series studies 2013 Québec City
• Development of a quality standards on allergology for German physicians 1997 Amsterdam
• Development of a question-driven framework for evidence rating in the area of communicable diseases—a project of the European Centre for Disease Prevention and Control (ECDC) 2013 Québec City
• Development of a questionnaire measuring individual goals of health information seeking (GAINS) 2018 Edinburgh
• Development of a rating for patient motivation in digital health intervention studies 2024 Prague [Global Evidence Summit]
• Development of a reporting guideline for scientific machine learning–based studies 2024 Prague [Global Evidence Summit]
• Development of a sclerotherapy simulator for training and propagating medical evidence 2019 Santiago
• Development of a search strategy for studies about patients’ values and preferences 2014 Hyderabad
• Development of a search strategy to identify evaluations of the performance of wound measurement instruments 2005 Melbourne
• Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE 1996 Adelaide
• Development of a shared decision-making aid - "Pain control options for gynecological surgery patients" 2024 Prague [Global Evidence Summit]
• Development of a software tool to facilitate the literature selection process for systematic reviews 2010 Keystone
• Development of a STandard reporting guideline for Evidence briefs for Policy: a STEP tool 2024 Prague [Global Evidence Summit]
• Development of a systematic review unit of the Botucatu Medical School (FMB), São Paulo State University in Brazil 2011 Madrid
• Development of a systematic review unit of the Study Centre of the German Surgical Society (SDGC) 2009 Singapore
• Development of a theoretical framework and an operationalized tool for supporting health-system guidance implementation 2024 Prague [Global Evidence Summit]
• Development of a theoretical framework to support health-system guidance implementation using a critical interpretive synthesis approach 2023 London
• Development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions 2024 Prague [Global Evidence Summit]
• Development of a tool to assess the trustworthiness of clinical decision support systems 2024 Prague [Global Evidence Summit]
• Development of a tool to evaluate the quality of observational studies 2008 Freiburg
• Development of a topic nomination and selection process with US Medicaid policy makers 2013 Québec City
• Development of a traditional Chinese medicine taxonomy for Embase 2018 Edinburgh
• Development of a transparent proposal process for guidelines focused on uncertainties in clinical care 2017 Cape Town [Global Evidence Summit]
• Development of a unified database based on CDISC for individual patient data (IPD) analysis: practices in reproductive health survey 2015 Vienna
• Development of a useful system for grading of recommendations and its application on the Korean Guideline 2015 Vienna
• Development of a web based software tool to improve the efficiency and user experience of systematic reviews 2012 Auckland
• Development of AMSTAR 2 2016 Seoul
• Development of an a-priori decision framework that weighs contextual factors to determine the acceptable certainty of evidence for clinical decision-making 2024 Prague [Global Evidence Summit]
• Development of an algorithm for choosing study designs 2015 Vienna
• Development of an approach to conduct and report scoping reviews 2017 Cape Town [Global Evidence Summit]
• Development of an English Health-Related Quality of Life (HRQoL) instrument for very young children, to be completed by proxy 2017 Cape Town [Global Evidence Summit]
• Development of an equity assessment tool to improve the quality and applicability of systematic reviews 2006 Dublin
• Development of an evidence base to support global hepatitis elimination 2020 Abstracts
• Development of an evidence- and narrative-based patient decision aid for secondary prevention of myocardial infarction 2017 Cape Town [Global Evidence Summit]
• Development of an evidence-based curriculum using Cochrane systematic reviews and tools in a learning healthcare system 2020 Abstracts
• Development of an evidence-based guideline when evidence is scarce: the importance of a balanced guideline panel 2019 Santiago
• Development of an evidence-based medicine (EBM) research centre in a Brazilian medical school 2019 Santiago
• Development of an Evidence-Based Nursing Information System in Taiwan 2017 Cape Town [Global Evidence Summit]
• Development of an evidence-based prediction model for medical usage at mass gatherings: interaction of evidence, expertise, and end-user demands 2020 Abstracts
• Development of an ICC database and imputation model facilitated meta-analysis of outcomes from cluster randomized trials 2020 Abstracts
• Development of an IDEAL-Rehab Framework to Guide Study Design and Conduct Evaluations of Rehabilitation Interventions 2024 Prague [Global Evidence Summit]
• Development of an implementation plan to implement a set of 5 dietary guidelines within dietetics 2024 Prague [Global Evidence Summit]
• Development of an innovative theory-based instrument to assess the impact of continuing professional development activities on clinical practice 2013 Québec City
• Development of an instrument to rate the credibility of a sub-group analysis 2010 Keystone
• Development of an objectively derived and validated search strategy to retrieve overviews of systematic reviews in MEDLINE 2015 Vienna
• Development of an Optimal Search Strategy for Finding Trials Demonstrating ACE Inhibitor Blood Pressure Lowering Efficacy 2002 Stavanger
• Development of an optimal search strategy for the retrieval of controlled trials using PubMed 1998 Baltimore
• Development of an ultrasound-guided vascular access simulator for training and propagating Cochrane evidence 2019 Santiago
• Development of Clinical Practice Guidelines in Rare Diseases: Identification of Gaps and Critical Appraisal of Scientific Evidence. 2024 Prague [Global Evidence Summit]
• Development of clinical research support system for conditional coverage with evidence development 2015 Vienna
• Development of Cochrane research synthesis in Thailand 2004 Ottawa
• Development of evidence-based clinical practice guidelines for Korean medicine: an introductory workshop 2016 Seoul
• Development of evidence-based medicine: From the perspective og the Cochrane Colloquium 2017 Cape Town [Global Evidence Summit]
• Development of good practice statements (GPSs) for the prevention of colorectal cancer 2024 Prague [Global Evidence Summit]
• Development of guidelines on the appropriate use of antibiotics for the local context ─ experiences from Singapore 2024 Prague [Global Evidence Summit]
• Development of guidelines with the collaboration of members from a pool of experts: design and interim experience from ECICC 2024 Prague [Global Evidence Summit]
• Development of high-performing population search filters is feasible and their use warranted in systematic reviews and clinical practice guidelines 2013 Québec City
• Development of knowledge brokering intervention model based on a systematic review 2013 Québec City
• Development of medical and tecnhological documents on standardisation of medical care in cardiovascular diseases in Ukraine 2017 Cape Town [Global Evidence Summit]
• Development of plain-language summaries of knowledge syntheses and other published research on zoonotic and environmental public health issues in Canada 2014 Hyderabad
• Development of PRITEM reporting guidance for mapping reviews 2024 Prague [Global Evidence Summit]
• Development of Rapid Recommendation: Necessity of ICU stay in patients with stroke and TIA 2024 Prague [Global Evidence Summit]
• Development of search strategies for retrieving studies on the accuracy of signs and symptoms 2008 Freiburg
• Development of search strategies to identify reports of off- label drug use in MEDLINE 2011 Madrid
• Development of section for evidence-based health care in National Institutes of Health and the Ministry of Health, Malaysia 2019 Santiago
• Development of the CochrAne qualitative MEthodological LimitatiOns Tool (CAMELOT) 2024 Prague [Global Evidence Summit]
• Development of the Dementia and Cognitive Improvement Group Specialized Register 2008 Freiburg
• Development of the Dutch translational knowledge agenda for inherited metabolic diseases 2024 Prague [Global Evidence Summit]
• Development of the European Guidelines on breast cancer screening and diagnosis. 2020 Abstracts
• Development of the first Academic League of Evidence-based Medicine in Brazil. A partnership between the Brazilian Cochrane Centre and Universidade Federal de São Paulo 2015 Vienna
• Development of the Iberoamerican Clinical Trials and Journals Database: BADERI 2016 Seoul
• Development of the McHarm: A tool evaluating validity of the collection and reporting of harms 2011 Madrid
• Development of the Portland Observational Study Screening Tool of Interventions (POST-I) to prioritize studies for a Cochrane Systematic Review 2019 Santiago
• Development of the PRISMA harms extension 2013 Québec City
• Development of the Spanish Cochrane Collaboration (1995-1997) 1997 Amsterdam
• Development of user-friendly evidence summaries for the rational use of essential medicines and other complex drugs in the Americas 2013 Québec City
• Development of user-friendly summaries for published systematic reviews and meta-analyses in agri-food public health 2013 Québec City
• Development of workable solutions to overcome known limitations of overview methodology 2018 Edinburgh
• Development plan of Cochrane Review evidence dissemination platform via public media WeChat in China 2018 Edinburgh
• Development, testing and validation of a taxonomy for outcomes in medical research to improve knowledge discovery 2018 Edinburgh
• Developmental evaluation of a Knowledge Translation Infrastructure: its collaborative governance and the implementation of its knowledge translation services 2024 Prague [Global Evidence Summit]
• Developments in handsearching - an international and health promotion and public health perspective 2006 Dublin
• Deworming children to improve growth and school performance: evidence update on a global health policy 2008 Freiburg
• Diagnosing and treating chronic abacterial prostatitis: a systematic review 2000 Cape Town
• Diagnosis and Prediction of Different Machine Learning methods for Knee Osteoarthritis: a protocol for a systematic review 2020 Abstracts
• Diagnosis and Prediction of Different Machine Learning methods for Knee Osteoarthritis: a systematic review and meta-analysis 2020 Abstracts
• Diagnosis and treatment of early colorectal cancer (stages I and II): a trustworthy clinical practice guideline 2019 Santiago
• Diagnostic accuracy and detection rate of real-time PCR for Group B Streptococcus with pregnant women 2017 Cape Town [Global Evidence Summit]
• Diagnostic accuracy of 18F-Prostate Specific Membrane Antigen (PSMA) PET/CT in staging of patients with high-risk prostate cancer or biochemical recurrence 2024 Prague [Global Evidence Summit]
• Diagnostic Accuracy of Canadian C-spine rule and NEXUS for detecting clinically important cervical spine injury following blunt trauma 2020 Abstracts
• Diagnostic accuracy of human metapneumovirus. Systematic review 2010 Keystone
• Diagnostic accuracy of machine-learning-assisted detection for anterior cruciate ligament and meniscal injuries based on magnetic resonance imaging: protocol for a systematic review and meta-analysis 2020 Abstracts
• Diagnostic methods for maxillary sinusitis: a systematic review 1997 Amsterdam
• Diagnostic studies and Cochrane systematic reviews: incompatible entities? What we can learn from a diagnostic RCT in vascular surgery 2004 Ottawa
• Diagnostic test accuracy Cochrane systematic reviews in schizophrenia: optimizing screening of articles 2012 Auckland
• Diagnostic test accuracy network meta-analysis methods: A scoping review and empirical assessment 2023 London
• Diagnostic test accuracy reviews 1: Introduction to meta-analysis 2012 Auckland
• Diagnostic test accuracy reviews 2: Assessment of methodological quality 2012 Auckland
• Diagnostic test accuracy reviews 3: Advanced meta-analysis – dealing with heterogeneity and test comparisons 2012 Auckland
• Diagnostic test accuracy reviews: advanced meta-analysis - dealing with heterogeneity and test comparisons 2015 Vienna
• Diagnostic test accuracy reviews: introduction to meta-analysis 2013 Québec City
• Diagnostic test risk of bias and applicability: how detailed and explicit should criteria be? 2012 Auckland
• Diagnostic validity of clinical tests in temporomandibular disorders: a meta-analysis 1994 Hamilton
• Diagnostic value of digital rectal examination (DRE) for detection of prostate cancer: the influence of methodological characteristics on outcome 1997 Amsterdam
• Diagnostic value of digital rectal examination (DRE) for detection of prostate cancer: the influence of methodological characteristics on outcome 1996 Adelaide
• Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy 2020 Abstracts
• Dialogue trumps preferences: A qualitative study of the influence of patient preferences on rehabilitation 2017 Cape Town [Global Evidence Summit]
• DianaHealth.com: Dissemination of Initiatives to ANalyse Appropriateness in healthcare 2014 Hyderabad
• Did non-Cochrane systematic reviews of nursing follow the protocols registered in the International Prospective Register of Systematic Reviews (PROSPERO) ? 2019 Santiago
• Did randomized trials evaluating pharmacological treatments for non-severe COVID-19 prioritize patient-important outcomes in their results? 2023 London
• Did the authors have full access to the data? Comparison of protocols and reports of industry-initiated trials in The Lancet 2010 Keystone
• Diet in cardiovascular diseases: an overview of umbrella reviews and overviews of reviews 2024 Prague [Global Evidence Summit]
• Dietary recommendations for the obese and overweight: A systematic survey of global guidelines 2020 Abstracts
• Dietitian’s perspectives of systematically reviewed interventions enhancing adherence to dietary advice for preventing and managing chronic diseases in adults: a Delphi study 2013 Québec City
• Difference between scoping reviews and mapping reviews in the evidence ecosystem 2023 London
• Differences between actual practice and return-to-work interventions studied in a Cochrane Review – a de-implementation case study 2019 Santiago
• Differences between Information Provided in Abstracts of Randomized Controlled Trials in Neonates Submitted to the Annual Meeting of the American Pediatric Society and the Society for Pediatric Research (APS/SPR) and Final Publications - Implication 1999 Rome
• Differences between messages and recommendations 1997 Amsterdam
• Differences in addressing heterogeneity in Cochrane reviews 2010 Keystone
• Differences in assessment of certainty of evidence by methodologists versus content experts 2019 Santiago
• Differences in database performance for retrieving reports of randomised and qualitative studies: experiences from a mixed-methods review 2020 Abstracts
• Differences in search strategies and output between Cochrane Reviews and matching Health Technology Assessment (HTA) report 2023 London
• Differences in the characteristics of exclusions in randomised trials based on the type of the intention-to-treat reporting 2015 Vienna
• Different approaches to appraising systematic reviews of salt intake for health outcomes using AMSTAR 2 tool: Cross-section study 2024 Prague [Global Evidence Summit]
• Different conclusions drawn from same topic: What and why? 2011 Madrid
• Different evidence synthesis products to inform different decisions. 2024 Prague [Global Evidence Summit]
• Different intermittent fasting regimens in adults with overweight or obesity: a systematic review and network meta-analysis of randomised controlled trials 2024 Prague [Global Evidence Summit]
• Different mortality time-points in critical care trials: current practice and influence on effect estimates 2015 Vienna
• Different Sampling Strategies For Identifying Eligible Studies: The Effect On Outcome Of A Meta-analysis Of Nonsteroidal Antiinflammatory Drug-associated Dyspepsia 1999 Rome
• Differential Impact of Exercises on Cardiorespiratory Fitness improve in Breast cancer survivors: A Network Meta -Analysis of Randomized Controlled Trails 2024 Prague [Global Evidence Summit]
• Differential reporting of subgroup analyses in trials between high impact and lower impact journals 2009 Singapore
• Differing use of core outcome sets in clinical guidelines for rheumatoid arthritis 2019 Santiago
• Difficult decision-making on weight-bearing exercise recommendation for women evaluation of the effect of a without-weight bearing walking intervention on bone mineral density among menopausal women 2010 Keystone
• Difficulty defining comparisons in Cochrane systematic reviews of rehabilitation interventions 2006 Dublin
• Difficulty in combining results of primary studies in the addiction field: need to enhance consistency of reported outcomes 2015 Vienna
• Digital Chronic Pain Recommendations Map: Consolidation and Systematic Appraisal of Guideline Recommendations Regarding Management of Chronic Pain (e-ChronicPain RecMap) 2024 Prague [Global Evidence Summit]
• Digital data collection for rigorous, randomised research 2017 Cape Town [Global Evidence Summit]
• Digital dissemination: advancing methodological awareness in evidence synthesis 2024 Prague [Global Evidence Summit]
• Digital gender-inclusive tools for evidence use—developing a prototype in Uganda 2024 Prague [Global Evidence Summit]
• Digital Health to support information, communication and data management in reproductive planning: a systematic review 2024 Prague [Global Evidence Summit]
• Dihydroartemisinin-piperaquine versus Sulfadoxine-pyrimethamine for malaria during pregnancy: A systematic review and meta-analysis of randomized controlled trials 2020 Abstracts
• Dilemma of Sham Needles in Acupuncture Research: A Scoping Review 2024 Prague [Global Evidence Summit]
• Dilemmas and solutions for conducting systematic reviews in social welfare 2024 Prague [Global Evidence Summit]
• Dipeptidyl peptidase-4 (DPP-4) inhibitors and hypoglycaemia risk in patients with type 2 diabetes mellitus (T2DM): a network meta-analysis 2016 Seoul
• Direct and indirect comparison of complex healthcare interventions in overview of reviews: non-pharmacological interventions for non-specific low back pain 2010 Keystone
• Direct versus indirect comparisons in systematic reviews of test accuracy studies: an IPD case study in ovarian reserve testing 2013 Québec City
• Disability inclusive elections in Africa: A systematic review of published and unpublished literature 2017 Cape Town [Global Evidence Summit]
• Disability stigma reduction: global evidence to local realities in Ghana 2024 Prague [Global Evidence Summit]
• Discernment of academic conflicts of interest for Cochrane Systematic Reviews 2015 Vienna
• Discharge planning for heart failure patients in a tertiary hospital in Shanghai: A best-practice implementation project 2017 Cape Town [Global Evidence Summit]
• Discharged patients' PRO-AEs provide credible evidence of in-hospital adverse events 2023 London
• Disclosure and handling conflicts of interest in the clinical practice guidelines programme in Colombia 2017 Cape Town [Global Evidence Summit]
• Disclosure and management of conflicts of interests in clinical practice guidelines 2017 Cape Town [Global Evidence Summit]
• Discontinuation and publication of randomized clinical trials supported by the Swiss National Science Foundation 2016 Seoul
• Discordant recommendations – Challenges in guideline synopses 2017 Cape Town [Global Evidence Summit]
• Discovering the voice of the Cochrane Library customer 2018 Edinburgh
• Discrepancies between registered protocol and final publication in exercise interventions for chronic low back pain: a meta-research study 2023 London
• Discrepancies between the prediction interval of network meta-analyses and subsequent randomized controlled trials 2016 Seoul
• Discrepancies in 'evidence-based' practice guidelines for diagnostic lumbar discography 2015 Vienna
• Discrepancies in effect estimates of randomized clinical trials between low/middle-income and high-income countries: A meta-research study 2023 London
• Discrepancies in outcome reporting exist between protocols and published oral health Cochrane Reviews 2015 Vienna
• Discrepancy between direct comparison and adjusted indirect comparison of new versus conventional pharmaceutical interventions 2006 Dublin
• Discrepancy in relative test performance due to modelling strategy in comparative diagnostic meta-analysis: A case study 2011 Madrid
• Discussing the challenges and impacts of a knowledge translation strategy, tailored for public health 2012 Auckland
• Discussing the risks and benefits of opioid use for chronic non-cancer pain (CNCP) 2015 Vienna
• Discussion on Chengdu essential medicine list by analyzing drug use in primary health institutions 2008 Freiburg
• Discussion section of Cochrane Reviews: is it supported by systematic reviews? 2018 Edinburgh
• Disease Burden of Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-analysis 2024 Prague [Global Evidence Summit]
• Disentangling publication bias and heterogeneity 2000 Cape Town
• Disentangling the data: variations in data submissions from different players and their potential impact on a systematic review 2005 Melbourne
• Disseminating and implementing practice guidelines: findings from the U.S. Agency for Health Care Policy & Research 1997 Amsterdam
• Disseminating and implementing practice guidelines: findings from the U.S. Agency for Health Care Policy & Research 1997 Amsterdam
• Disseminating Cochrane evidence 2016 Seoul
• Disseminating Cochrane evidence in German via Instagram: Concept, channel performance and audience characteristics of our Insta channel “cochrane_deutschland” 2023 London
• Disseminating Cochrane evidence to a wider audience through social media 2019 Santiago
• Disseminating Cochrane evidence to the public health workforce via author-led webinars 2016 Seoul
• Disseminating Cochrane evidence using context-specific methods: two case studies from Pakistan and the USA 2019 Santiago
• Disseminating Cochrane evidence with the leading social media on mobile phones in China 2017 Cape Town [Global Evidence Summit]
• Disseminating Cochrane findings to consumers through online, animated video summaries 2016 Seoul
• Disseminating evidence to health care practitioners on the Instagram: an ecological study. 2020 Abstracts
• Disseminating good evidence for Cochrane Systematic Reviews: practice and experience from China 2015 Vienna
• Disseminating information on medicines and health interventions in Brazilian Portuguese using a internet-based resource: the Cemeds’ Blog 2013 Québec City
• Disseminating knowledge for evidence-based cancer care - National Knowledge Weeks 2006 Dublin
• Disseminating research findings to professional and lay audiences: a case study 1997 Amsterdam
• Disseminating research findings to professional and lay audiences: a case study 1997 Amsterdam
• Disseminating results of systematic reviews through a TV show in Brazil 1998 Baltimore